Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise)

Active Ingredient:
exenatide
Company:  
AstraZeneca UK Limited See contact details
ATC code: 
A10BJ01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Product Information HCP Med Info
{arrow_left}
{arrow_right}

The user manual gives instructions on how to safely and effectively administer your medicine. It should be read in conjunction with the patient leaflet.

{pdf} View or print the user manual as PDF
AstraZeneca UK Limited
Company image
Address
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
Telephone
+44 (0)1582 836 000
Fax
+44 (0)1582 838 000
Medical Information Direct Line
0800 783 0033
Medical Information e-mail
[email protected]
Medical Information Website
https://medicalinformation.astrazeneca.co.uk/
Medical Information Website
www.myazmed.co.uk